U
BEAT

UBS’s BioTelemetry, Inc. BEAT Stock Holding History

UBS’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7K Sell
1,000
-53,300
-98% -$374K ﹤0.01% 9236
2014
Q2 		$389K Buy
54,300
+3,400
+7% +$27.1K ﹤0.01% 4467
2014
Q1 		$514K Sell
50,900
-7,300
-13% -$67.2K ﹤0.01% 4207
2013
Q4 		$462K Buy
58,200
+51,600
+782% +$482K ﹤0.01% 4430
2013
Q3 		$65K Buy
+6,600
New +$51.9K ﹤0.01% 6533

Other funds holding BEAT

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

UBS's BEAT Position: Q3 2014 in Review

UBS reduced its BioTelemetry, Inc. (BEAT) stake by 20% in Q3 2014, selling an estimated $97.8K and leaving 57,376 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #4535.

UBS first reported a position in BEAT in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.25M in Q1 2014. 85 funds tracked by Wall St. Rank hold BEAT as of Q3 2014.

  • UBS held 57,376 shares of BioTelemetry, Inc. worth $385K as of Q3 2014.
  • UBS sold 13,949 BioTelemetry, Inc. shares in Q3 2014, an estimated $97.8K.
  • BioTelemetry, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4535 holding.
  • UBS first reported a position in BioTelemetry, Inc. in Q2 2013 and has held it in 6 quarters since.
  • UBS's BioTelemetry, Inc. position peaked at $1.25M in Q1 2014.
  • 85 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.